Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The reasons for revising the earnings forecast are not provided.
Restructuring-related costs and impairment loss: negative ¥2,069 million (shown in aggregate). The statement of cash flows, however, lists an impairment loss of negative ¥29 million.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥3,540,000 million |
| Operating profit | Not disclosed → ¥430,000 million |
| Profit attributable to owners of the parent | Not disclosed → ¥290,000 million |
| Net income per share | Not disclosed → 218.65 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Reason for the revision | The reasons for revising the earnings forecast are not provided. |
| Details and amount of extraordinary loss | Restructuring-related costs and impairment loss: negative ¥2,069 million (shown in aggregate). The statement of cash flows, however, lists an impairment loss of negative ¥29 million. |
| Dividend forecast revision | No revision |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reasons for revising the earnings forecast are not provided in this financial results summary.